Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


New research looks at "dog breath

New research looks at the benefit of BLIS K12™ probiotic in dogs

BLIS Technologies Ltd (NZX:BLT) announces the successful completion of the first phase in a research programme, which focuses on preventing bad breath in dogs. According to the programme leader at BLIS Technologies, Dr John Hale the BLIS K12™ probiotic, which is already known for its ability to inhibit bacteria responsible for the severe bad breath in humans, has been given to dogs to determine if bad breath can be reduced or eliminated in companion animals.

“The trial was a pilot study to determine the viability of the BLIS K12™ probiotic in a dog’s mouth, using either a liquid and solid dose form” Hale said. “The results from this small pilot trial were encouraging enough to commence a longer, extended dosing trial in dogs, which started in Dunedin last week”

The study was made possible through collaboration between BLIS Technologies and the Otago Polytechnic School of Veterinary Nursing, where many of the staff have volunteered their own dogs for the trial. BLIS Technologies has already undertaken bench-top studies in their own laboratory and found that their BLIS K12™ probiotic was able to inhibit around 50% of the various bacteria of a dog’s mouth and this is a big part of the reason why the Company has undertaken these trials in dogs.

Bacterial infections of the teeth and gums in dogs and cats are increasing problem, according to the veterinary industry and while BLIS Technologies is currently just focused on bacterial bad breath in dogs, it is hoped that the Company could eventually expand its research into the animal periodontal area.

"This research represents further evidence that the BLIS K12™ probiotic is a highly versatile organism and plays an important role in the Company’s commercial strategy " said Dr Barry Richardson, Chief Executive of BLIS Technologies. "We believe that this early data points to a beneficial effect in dogs and we would expect further studies to confirm this effect before commercialization in the animal market."


© Scoop Media

Business Headlines | Sci-Tech Headlines


Seeking 'Clarity': Crown To Appeal Southern Response Decision, Offers Costs

“It is our intention that the clarity that will come from the outcome of these proceedings will enable the Crown to work with Southern Response to provide a soundly based proactive solution to those people that are affected.” More>>

Thinking Of The Children: Plan For Classification For Commercial Video On Demand

Classifying on-demand video content will be made mandatory to bring it in line with other media and provide better guidance and protections to families and young people, says Internal Affairs Minister Tracey Martin. More>>

Cheques Out: Inland Revenue And ACC Push For Paperless

Inland Revenue and the Accident Compensation Corporation are calling ‘time’ on cheques. From March next year, IR and ACC will no longer accept payments by cheque from customers who are able to use alternative payment options. More>>


"Vision And Growth": Capital Markets 2029 Report

Broader participation by New Zealanders, greater access to growth capital for New Zealand enterprises, and more choices for investors drive the recommendations in the Capital Markets 2029 report released today. More>>


Forest & Bird: Call For More Funding To Stop Plague Of Wallabies

Wallabies could spread over a third of New Zealand within the next 50 years, unless control is increased dramatically, says Forest & Bird central North Island regional manager Rebecca Stirnemann. More>>